BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29208209)

  • 1. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
    Neßler J; Rundfeldt C; Löscher W; Kostic D; Keefe T; Tipold A
    BMC Vet Res; 2017 Jan; 13(1):33. PubMed ID: 28118828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptic seizure frequency and semiology in dogs with idiopathic epilepsy after initiation of imepitoin or phenobarbital monotherapy.
    Stabile F; van Dijk J; Barnett CR; De Risio L
    Vet J; 2019 Jul; 249():53-57. PubMed ID: 31239165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy.
    Dewey CW; Cerda-Gonzalez S; Levine JM; Badgley BL; Ducoté JM; Silver GM; Cooper JJ; Packer RA; Lavely JA
    J Am Vet Med Assoc; 2009 Dec; 235(12):1442-9. PubMed ID: 20001779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
    Tipold A; Keefe TJ; Löscher W; Rundfeldt C; de Vries F
    J Vet Pharmacol Ther; 2015 Apr; 38(2):160-8. PubMed ID: 25079881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic drug therapy.
    Podell M
    Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent.
    Govendir M; Perkins M; Malik R
    Aust Vet J; 2005 Oct; 83(10):602-8. PubMed ID: 16255282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromide therapy in refractory canine idiopathic epilepsy.
    Podell M; Fenner WR
    J Vet Intern Med; 1993; 7(5):318-27. PubMed ID: 8263851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.
    Rundfeldt C; Tipold A; Löscher W
    BMC Vet Res; 2015 Sep; 11():228. PubMed ID: 26330063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatitis associated with potassium bromide/phenobarbital combination therapy in epileptic dogs.
    Gaskill CL; Cribb AE
    Can Vet J; 2000 Jul; 41(7):555-8. PubMed ID: 10907578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of imepitoin in the treatment of naive dogs affected by idiopathic epilepsy.
    Gallucci A; Gagliardo T; Menchetti M; Bianchi E; Bucci D; Gandini G
    Vet Rec; 2017 Aug; 181(6):144. PubMed ID: 28600446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy.
    Packer RM; De Risio L; Volk HA
    BMC Vet Res; 2017 Apr; 13(1):90. PubMed ID: 28388948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs.
    Löscher W; Hoffmann K; Twele F; Potschka H; Töllner K
    Pharmacol Res; 2013 Nov; 77():39-46. PubMed ID: 24056205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of bromide in therapy resistant epilepsy of dogs].
    Schwartz-Porsche D; Jürgens U
    Tierarztl Prax; 1991 Aug; 19(4):395-401. PubMed ID: 1948987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of imepitoin, a recently developed antiepileptic drug, on thyroid parameters and fat metabolism in healthy Beagle dogs.
    Bossens K; Daminet S; Duchateau L; Rick M; Van Ham L; Bhatti S
    Vet J; 2016 Jul; 213():48-52. PubMed ID: 27240915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.
    Heske L; Körberg IB; Nødtvedt A; Jäderlund KH
    Acta Vet Scand; 2015 Nov; 57():75. PubMed ID: 26546467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.